Dr. Claire Verschraegen earned her medical degree from Universite Libre De Bruxelles. She completed her internal medicine residency at the University of Texas Health Sciences Center and her hematology/oncology fellowship at the MD Anderson Cancer Center. She also performed research at the Christus Stehlin Foundation for Cancer Research.
Dr. Verschraegen currently practices as a medical oncologist at the Ohio State University College of Medicine, where she also serves as Director of the Division of Medical Oncology, Professor, and Chair in Innovative Cancer Research. She holds an additional position as Associate Director for Translational Research at the Ohio State University Comprehensive Cancer Center. Mesothelioma is one of her special areas of interest.
Dr. Claire Verschraegen is nationally recognized for her work as a researcher, mentor, and clinician. She has a proven track record in treating mesothelioma.
National Recognition for Research and Patient Care
Dr. Verschraegen is nationally recognized for her work as a researcher, mentor, and clinician. She has a proven track record in treating mesothelioma. Her research carried out in phase 1, phase 2, and phase 3 clinical trials has been funded for more than 20 years by the National Cancer Institute. Dr. Verschraegen works to create novel targeted therapies and immunotherapies to treat mesothelioma.
When faced with a diagnosis of mesothelioma, it is crucial to find the right treatment right away. Contact Dr. Claire Verschraegen today to be connected with treatment through a clinical trial.